Carcinoid syndrome causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 30: | Line 30: | ||
|} | |} | ||
*'''Genetic mutations''' | *'''[[Genetic mutations]]''' | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center" |
Revision as of 17:06, 18 April 2019
Carcinoid syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Carcinoid syndrome causes On the Web |
American Roentgen Ray Society Images of Carcinoid syndrome causes |
Risk calculators and risk factors for Carcinoid syndrome causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Common causes of carcinoid syndrome include genetic disorders (multiple endocrine neoplasia type 1 and neurofibromatosis type 1) and genetic mutations (gains involving chromosomes 5, 14, 17, and 19 and losses involving chromosomes 11 and 18).
Causes
- Approximately 30-40% of patients with well-differentiated neuroendocrine tumors present with carcinoid syndrome.
- Carcinoid syndrome is predominantly associated with neuroendocrine tumors (NETs) that arise from the midgut in the setting of extensive liver metastases
- Carcinoid syndrome may be present in patients with bronchial carcinoids.[1]
- other common causes of carcinoid syndrome includes are mostly genetic:[2]
- Genetic disorders
Genetic Disorder | Tumor Location |
---|---|
| |
|
Type of Mutation | Chromosomes |
---|---|
Gains |
|
Losses |
|
References
- ↑ Rubin de Celis Ferrari AC, Glasberg J, Riechelmann RP (August 2018). "Carcinoid syndrome: update on the pathophysiology and treatment". Clinics (Sao Paulo). 73 (suppl 1): e490s. doi:10.6061/clinics/2018/e490s. PMC 6096975. PMID 30133565.
- ↑ Molecular genetics. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq